Idaho Cannabis Legislation

H0879 legalizes the sale of hemp products for human consumption in Idaho, impacting consumers and the nascent hemp industry.

SCR127 urges Idaho citizens to reject the Idaho Medical Cannabis Act ballot initiative, signaling legislative opposition to medical cannabis legalization.

Idaho H0777 revises controlled substances law, impacting patients, consumers, and operators by altering cannabis-related regulations starting July 1, 2026.

H0864 adds mitragynine (kratom) to Idaho's Schedule I controlled substances, restricting access for consumers and potentially creating new criminal penalties.

H0830 adds kratom alkaloids to Idaho's Schedule I controlled substances, restricting public access and criminalizing possession.

H0771 allowed the sale of industrial hemp products in Idaho, creating a new market for consumers and operators.

H0497 revises Idaho's controlled substances law, maintaining cannabis prohibition and impacting patients, consumers, and operators by continuing to criminalize its use and sale.